South Korea · Delayed Price · Currency is KRW CellBion Statistics
Total Valuation
CellBion has a market cap or net worth of KRW 222.10 billion. The enterprise value is 210.19 billion.
| Market Cap | 222.10B |
| Enterprise Value | 210.19B |
Important Dates
The last earnings date was Monday, April 13, 2026.
| Earnings Date | Apr 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CellBion has 12.91 million shares outstanding. The number of shares has increased by 0.17% in one year.
| Current Share Class | 12.91M |
| Shares Outstanding | 12.91M |
| Shares Change (YoY) | +0.17% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 36.28% |
| Owned by Institutions (%) | 3.51% |
| Float | 8.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 106.88 |
| PB Ratio | 10.80 |
| P/TBV Ratio | 11.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 101.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.95, with a Debt / Equity ratio of 0.40.
| Current Ratio | 11.95 |
| Quick Ratio | 11.47 |
| Debt / Equity | 0.40 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.90 |
| Interest Coverage | -42.96 |
Financial Efficiency
Return on equity (ROE) is -35.08% and return on invested capital (ROIC) is -18.92%.
| Return on Equity (ROE) | -35.08% |
| Return on Assets (ROA) | -17.06% |
| Return on Invested Capital (ROIC) | -18.92% |
| Return on Capital Employed (ROCE) | -29.54% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 37.78M |
| Profits Per Employee | -155.35M |
| Employee Count | 55 |
| Asset Turnover | 0.06 |
| Inventory Turnover | 5.02 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.15% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -22.15% |
| 50-Day Moving Average | 25,722.60 |
| 200-Day Moving Average | 24,214.35 |
| Relative Strength Index (RSI) | 22.91 |
| Average Volume (20 Days) | 55,639 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CellBion had revenue of KRW 2.08 billion and -8.54 billion in losses. Loss per share was -666.35.
| Revenue | 2.08B |
| Gross Profit | -59.96M |
| Operating Income | -9.04B |
| Pretax Income | -8.54B |
| Net Income | -8.54B |
| EBITDA | -8.66B |
| EBIT | -9.04B |
| Loss Per Share | -666.35 |
Balance Sheet
The company has 20.24 billion in cash and 8.33 billion in debt, with a net cash position of 11.91 billion or 922.79 per share.
| Cash & Cash Equivalents | 20.24B |
| Total Debt | 8.33B |
| Net Cash | 11.91B |
| Net Cash Per Share | 922.79 |
| Equity (Book Value) | 20.57B |
| Book Value Per Share | 1,603.26 |
| Working Capital | 19.65B |
Cash Flow
In the last 12 months, operating cash flow was -6.51 billion and capital expenditures -2.72 billion, giving a free cash flow of -9.23 billion.
| Operating Cash Flow | -6.51B |
| Capital Expenditures | -2.72B |
| Depreciation & Amortization | 375.13M |
| Net Borrowing | -638.77M |
| Free Cash Flow | -9.23B |
| FCF Per Share | -715.01 |
Margins
| Gross Margin | -2.89% |
| Operating Margin | -434.87% |
| Pretax Margin | -411.18% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CellBion does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.17% |
| Shareholder Yield | -0.17% |
| Earnings Yield | -3.85% |
| FCF Yield | -4.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CellBion has an Altman Z-Score of 12.16 and a Piotroski F-Score of 2.
| Altman Z-Score | 12.16 |
| Piotroski F-Score | 2 |